Ironsides Asset Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-29,133
Closed -$485K 66
2024
Q1
$485K Buy
29,133
+3,606
+14% +$55.9K 0.17% 40
2023
Q4
$382K Hold
25,527
0.17% 40
2023
Q3
$370K Buy
25,527
+2,161
+9% +$32.3K 0.17% 45
2023
Q2
$354K Buy
23,366
+3,742
+19% +$56.2K 0.15% 49
2023
Q1
$297K Hold
19,624
0.14% 56
2022
Q4
$272K Buy
19,624
+6,437
+49% +$90.9K 0.12% 63
2022
Q3
$179K Sell
13,187
-579
-4% -$8.6K 0.08% 77
2022
Q2
$202K Buy
13,766
+2,587
+23% +$39.9K 0.08% 84
2022
Q1
$185K Buy
+11,179
New +$196K 0.06% 92

Other funds holding BCAT

Ironsides Asset Advisors's BCAT Position: Q2 2024 in Review

Ironsides Asset Advisors sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2024, closing a stake of 29,133 shares — an estimated $485K sold.

Ironsides Asset Advisors first reported a position in BCAT in Q1 2022 and held it in 9 quarters. The position peaked at $485K in Q1 2024. 86 funds tracked by Wall St. Rank hold BCAT as of Q2 2024.

  • Ironsides Asset Advisors reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2024 after selling out during the quarter.
  • Ironsides Asset Advisors sold 29,133 BlackRock Capital Allocation Term Trust shares in Q2 2024, an estimated $485K.
  • Ironsides Asset Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q1 2022 and held it in 9 quarters.
  • Ironsides Asset Advisors's BlackRock Capital Allocation Term Trust position peaked at $485K in Q1 2024.
  • 86 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2024.

Based on Ironsides Asset Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.